American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
暂无分享,去创建一个
Irl B Hirsch | Timothy S Bailey | Lois Jovanovič | Philip Levy | Derek LeRoith | Janet B McGill | Lawrence Blonde | Guillermo Umpierrez | G. Bray | J. McGill | I. Hirsch | H. Lebovitz | L. Jovanovič | K. Wyne | G. Grunberger | T. Bailey | L. Blonde | G. Umpierrez | A. Vinik | E. Horton | D. Leroith | R. Henry | A. Garber | J. Mechanick | Rachel Pessah-Pollack | Z. Bloomgarden | W. Garvey | D. Einhorn | O. Ganda | Y. Handelsman | P. Jellinger | J. Davidson | P. Levy | F. Zangeneh | S. Dagogo-Jack | R. Zimmerman | E. Orzeck | D. Hurley | Samuel Dagogo-Jack | Robert R Henry | George A Bray | Yehuda Handelsman | Zachary T Bloomgarden | J. Mestman | Jeffrey I Mechanick | George Grunberger | Jaime A Davidson | Daniel Einhorn | Alan J Garber | Edward S Horton | Paul S Jellinger | Etie S Moghissi | Eric A Orzeck | Aaron I Vinik | A. Cohen | E. Moghissi | P. Rosenblit | Robert S Zimmerman | A Jay Cohen | Om P Ganda | W Timothy Garvey | Daniel L Hurley | Harold E Lebovitz | Jorge H Mestman | Rachel Pessah-Pollack | Paul D Rosenblit | Kathleen Wyne | Farhad Zangeneh
[1] D. Willcox,et al. The Okinawan Diet: Health Implications of a Low-Calorie, Nutrient-Dense, Antioxidant-Rich Dietary Pattern Low in Glycemic Load , 2009, Journal of the American College of Nutrition.
[2] T. Erlinger,et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. , 2003, Diabetes care.
[3] P. Bennett,et al. Congenital Susceptibility to NIDDM: Role of Intrauterine Environment , 1988, Diabetes.
[4] E. Mannucci,et al. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. , 2013, The Journal of clinical psychiatry.
[5] G. Bray. A Guide to Obesity and the Metabolic Syndrome: Origins and Treatment , 2011 .
[6] M. Pathy,et al. Principles and practice of geriatric medicine , 2005 .
[7] H. Yoshikawa,et al. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model , 2010, Experimental Neurology.
[8] L. Melton,et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. , 1999, Diabetes care.
[9] P. Donnan,et al. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. , 2000, Diabetes care.
[10] R. Kirsner,et al. Clinical practice. Neuropathic diabetic foot ulcers. , 2004, The New England journal of medicine.
[11] H. Parving,et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.
[12] Nicola J Cooper,et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[13] L. Jovanovic,et al. Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes , 2012, Diabetes Care.
[14] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[15] M. Molitch,et al. A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency , 2012, Diabetes Care.
[16] S. Tunis,et al. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada. , 2009, Clinical therapeutics.
[17] L. Rydén,et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. , 2004, European heart journal.
[18] S. Cummings,et al. Thiazolidinedione use and bone loss in older diabetic adults. , 2006, The Journal of clinical endocrinology and metabolism.
[19] R. Hughes,et al. ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY , 2012, The Cochrane database of systematic reviews.
[20] G I Bell,et al. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.
[21] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[22] Michael Bailey,et al. Hypoglycemia and outcome in critically ill patients. , 2010, Mayo Clinic proceedings.
[23] A. Vinik,et al. Quantitative measurement of cutaneous perception in diabetic neuropathy , 1995, Muscle & nerve.
[24] J. Lau,et al. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. , 2007, JAMA.
[25] Devjit Tripathy,et al. Actos Now for the prevention of diabetes (ACT NOW) study , 2009, BMC endocrine disorders.
[26] Curt D. Furberg,et al. Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.
[27] V. Mohan. Epidemiology of Complications of Diabetes , 2014 .
[28] R. Ross,et al. Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. , 2012, Archives of internal medicine.
[29] R. Bilous,et al. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] M. Clearfield. Combination Lipid Therapy in Type 2 Diabetes , 2011, Current atherosclerosis reports.
[31] G. Cresci,et al. Postoperative diet advancement: surgical dogma vs evidence-based medicine. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[32] K. Schulman,et al. Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[33] D. Berrigan,et al. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. , 2006, Cancer research.
[34] B. Davis,et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.
[35] G. Umpierrez,et al. Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[36] Silvio E. Inzucchi,et al. Management of Hyperglycemia in the Hospital Setting , 2006 .
[37] J. Borén,et al. Review the Polygenic Nature of Hypertriglyceridaemia: Implications for Defi Nition, Diagnosis, and Management , 2022 .
[38] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.
[39] Roy A Kaplan,et al. Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study , 1998, Diabetes Care.
[40] Judith Wylie-Rosett,et al. Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.
[41] F. A. Gries,et al. The Epidemiology of Diabetic Neuropathy , 1993 .
[42] C. Lindgren,et al. Common Variants in Maturity-Onset Diabetes of the Young Genes and Future Risk of Type 2 Diabetes , 2008, Diabetes.
[43] O. Ganda,et al. Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[44] K. Jones,et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. , 2002, Diabetes care.
[45] F. Nieto,et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .
[46] R. Heine,et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.
[47] Henry Buchwald,et al. Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.
[48] D. Nieman,et al. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates , 2010 .
[49] C. Apovian,et al. Nutrition Recommendations and Interventions for Diabetes–2006 , 2006, Diabetes Care.
[50] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[51] Dennis D. Kim,et al. Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin , 2006, Diabetes/metabolism research and reviews.
[52] T. Wong,et al. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review , 2007, BMJ : British Medical Journal.
[53] Richard Hellman,et al. Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. , 2008, Physical therapy.
[54] J. Gallivan,et al. National Diabetes Education Program: opportunities and challenges. The National Diabetes Education Program Strategic Planning Committee. , 1998, Journal of the American Dietetic Association.
[55] P. O'Neil,et al. Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study , 2012, Obesity.
[56] J. Zonszein,et al. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. , 2011, The American journal of medicine.
[57] D. Flum,et al. Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program , 2012, Annals of surgery.
[58] G. Bray,et al. Pharmacologic Treatment Options for Obesity: What Is Old Is New Again , 2013, Current Hypertension Reports.
[59] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[60] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[61] P. Cavanagh,et al. Assessment and management of foot disease in patients with diabetes. , 1994, The New England journal of medicine.
[62] Seppo Lehto,et al. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. , 2005, Diabetes care.
[63] B. Zinman,et al. Rosiglitazone-Associated Fractures in Type 2 Diabetes , 2008, Diabetes Care.
[64] E. Wagner,et al. Medical Conditions and Motor Vehicle Collision Injuries in Older Adults , 1994, Journal of the American Geriatrics Society.
[65] A. Vinik,et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management , 2011, Diabetes/metabolism research and reviews.
[66] G. Umpierrez,et al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery , 2010, Diabetes Care.
[67] D. Nathan,et al. Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.
[68] William Weintraub,et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.
[69] L. Niskanen,et al. Comparison of Insulin Regimens in Patients with Non-Insulin Dependent Diabetes Mellitus , 1993 .
[70] A. Farmer,et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. , 2009, The New England journal of medicine.
[71] C. Iber,et al. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. , 2012, Sleep.
[72] James B Talmage,et al. Factors Associated With Obstructive Sleep Apnea Among Commercial Motor Vehicle Drivers , 2011, Journal of occupational and environmental medicine.
[73] Joyce Y. Wu,et al. Investigating maturity onset diabetes of the young. , 2009, The Clinical biochemist. Reviews.
[74] T. Marshall,et al. Dietary Guidelines for Americans, 2010: an update. , 2011, Journal of the American Dental Association.
[75] C. Schmid,et al. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. , 2004, Archives of internal medicine.
[76] J. Mann,et al. Trans fatty acids and cardiovascular health: translation of the evidence base. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[77] M. Kivimäki,et al. Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes , 2010, Diabetes Care.
[78] M. Marre,et al. Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits , 2009, Postgraduate medicine.
[79] B. Hutton,et al. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. , 2004, The American journal of clinical nutrition.
[80] A. Hofman,et al. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis , 2015, Diabetologia.
[81] Rajiv Raman,et al. The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.
[82] J. Garber,et al. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists--2014 Update and the AACe G4G Program. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[83] A. Palmer,et al. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[84] H. Hanaire. External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives. , 2011, Diabetes & metabolism.
[85] H. Rodbard,et al. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[86] Bertram L Kasiske,et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.
[87] B. Fernhall,et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. , 2010, Medicine and science in sports and exercise.
[88] Joseph L. Mills,et al. Comprehensive fool examination and risk assessment: A report of the task force of the foot care interest group of the American diabetes association, with endorsement by the American association of clinical endocrinologists , 2008 .
[89] J. Rosenstock,et al. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes , 2010, Diabetes, obesity & metabolism.
[90] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[91] L. Kozak,et al. National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.
[92] F. Gries,et al. Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.
[93] B. Zinman,et al. Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) , 2009, Diabetes Care.
[94] R. Manders,et al. Low-intensity exercise reduces the prevalence of hyperglycemia in type 2 diabetes. , 2010, Medicine and science in sports and exercise.
[95] E. van Cauter,et al. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. , 2008, Chest.
[96] Z. Bloomgarden. Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment (抑制钠葡萄糖转运体2:一种新的糖尿病治疗方法) , 2013, Journal of diabetes.
[97] Nicola Glover-Thomas,et al. Mental Health Professionals , 2010 .
[98] D. Sacks. A1C Versus Glucose Testing: A Comparison , 2011, Diabetes Care.
[99] G. Bray,et al. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[100] B. Ammori,et al. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis , 2010, Expert opinion on pharmacotherapy.
[101] F L Ferris,et al. Treatment of diabetic retinopathy. , 1999, The New England journal of medicine.
[102] Z. Bloomgarden,et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[103] J. Brunzell,et al. Clinical practice. Hypertriglyceridemia. , 2007, The New England journal of medicine.
[104] S. Gapstur,et al. Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults , 2012, Diabetes Care.
[105] R. Carney,et al. Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.
[106] M. Woodward,et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.
[107] Howard Wolpert,et al. Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes , 2009, Diabetes Care.
[108] T. Wadden,et al. One‐year Weight Losses in the Look AHEAD Study: Factors Associated With Success , 2009, Obesity.
[109] F. Greenway,et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial , 2010, The Lancet.
[110] G. Gronseth,et al. Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.
[111] G. Hitman,et al. Systematic review on urine albumin testing for early detection of diabetic complications. , 2005, Health technology assessment.
[112] E. Kohner,et al. Why some cases of retinopathy worsen when diabetic control improves , 1997, BMJ.
[113] A. Vinik,et al. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. , 2005, Diabetes technology & therapeutics.
[114] Martin Pitt,et al. Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy? , 2012, Diabetes Care.
[115] Braxton D Mitchell,et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.
[116] F. Rubino,et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[117] J. Leahy. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .
[118] D. Mozaffarian,et al. Saturated Fat and Cardiometabolic Risk Factors, Coronary Heart Disease, Stroke, and Diabetes: a Fresh Look at the Evidence , 2010, Lipids.
[119] Massimiliano Cazzaniga,et al. Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis , 2010, Cancer Prevention Research.
[120] B. Goldstein,et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes , 2010, BMC endocrine disorders.
[121] G. Fonarow,et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. , 2014, Journal of the American College of Cardiology.
[122] M. Taskinen. Diabetic dyslipidaemia: from basic research to clinical practice* , 2003, Diabetologia.
[123] D. Thurman,et al. Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40岁及以上人群的他汀使用情况与周围神经病变的关系) , 2013, Journal of diabetes.
[124] A. Vinik,et al. Neurovascular Function and Sudorimetry in Health and Disease , 2013, Current Diabetes Reports.
[125] W. Garvey,et al. Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. , 2014, Metabolic syndrome and related disorders.
[126] D. Heisey,et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. , 2000, Kidney international.
[127] K. Gadde,et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial , 2011, The Lancet.
[128] C. Schmid,et al. Long-term non-pharmacological weight loss interventions for adults with prediabetes. , 2005, The Cochrane database of systematic reviews.
[129] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[130] Deborah J. Cook,et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.
[131] S. Larsson,et al. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.
[132] W. Herman,et al. Underdiagnosis of peripheral neuropathy in type 2 diabetes. , 2005, Diabetes care.
[133] T. Wadden,et al. Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010 .
[134] P. Cryer,et al. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. , 2013, The New England journal of medicine.
[135] F. Pi‐Sunyer,et al. Carbohydrate issues: type and amount. , 2008, Journal of the American Dietetic Association.
[136] J. Derr,et al. Problems with Gait and Posture in Neuropathic Patients with Insulin‐Dependent Diabetes Mellitus , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[137] L. Rydén,et al. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart. , 2007, European heart journal.
[138] M. Stumvoll,et al. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. , 2000, The Journal of clinical endocrinology and metabolism.
[139] W. M. Anderson,et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[140] M. Laakso,et al. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data , 2004, Diabetologia.
[141] D. Leroith,et al. Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression , 2009, Diabetes.
[142] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[143] David R. Plas,et al. Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.
[144] Whei-Min Lin,et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. , 2004, Brain : a journal of neurology.
[145] A. Farmer,et al. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials , 2012, Diabetologia.
[146] G. Mamikunian,et al. Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation , 2011, Experimental diabetes research.
[147] P. Cryer,et al. Hypoglycemia in diabetes. , 2003, Diabetes care.
[148] Everett M. Rogers,et al. Consensus Development Conference , 1984 .
[149] Ivana Vucenik,et al. Annals of the New York Academy of Sciences Obesity and Cancer Risk: Evidence, Mechanisms, and Recommendations , 2022 .
[150] C. Weyer,et al. A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. , 2002, Diabetes care.
[151] P. Royle,et al. The use of metformin in type 1 diabetes: a systematic review of efficacy , 2010, Diabetologia.
[152] N. Marchionni,et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[153] A. López,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[154] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[155] L. Kennedy. A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes , 2007 .
[156] A. Al-Shaikh. COMPARISON OF BASAL INSULIN ADDED TO ORAL AGENTS VERSUS TWICE - DAILY PREMIXED INSULIN AS INITIAL INSULIN THERAPY FOR TYPE 2 DIABETES , 2006 .
[157] A. Garber. Long-Acting Glucagon-Like Peptide 1 Receptor Agonists , 2011, Diabetes Care.
[158] A. Bauman,et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. , 2007, Circulation.
[159] P. Davidson,et al. A Cause-and-Effect-Based Mathematical Curvilinear Model That Predicts the Effects of Self-Monitoring of Blood Glucose Frequency on Hemoglobin A1c and is Suitable for Statistical Correlations , 2007, Journal of diabetes science and technology.
[160] S. Majumdar,et al. Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study , 2014, Diabetologia.
[161] J. Rosenstock,et al. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. , 2003, Diabetes care.
[162] C. Mantzoros,et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis , 2007, Diabetologia.
[163] H. Krumholz,et al. Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.
[164] Limin Peng,et al. Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.
[165] Matthew Page,et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. , 2010, The Cochrane database of systematic reviews.
[166] H R Taylor,et al. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[167] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[168] O. Tanner. Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .
[169] W. Frishman. Effects of longterm fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialKeech A, and the FIELD study investigators (Univ of Sydney, Australia; et al) Lancet 366:1849–1861, 2005§ , 2007 .
[170] C. Bouchard,et al. Bariatric surgery and long-term cardiovascular events. , 2012, JAMA.
[171] G. Klingensmith,et al. ISPAD clinical practice consensus guidelines 2009 compendium. Introduction. , 2009, Pediatric diabetes.
[172] T Douglas Bradley,et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. , 2003, The New England journal of medicine.
[173] P. Thomas,et al. Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.
[174] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[175] Ralph L. Sacco,et al. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers , 2013, Circulation.
[176] Rodica Pop-Busui,et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.
[177] K. Gadde,et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study , 2011, The American journal of clinical nutrition.
[178] J. Halter,et al. Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.
[179] Limin Peng,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.
[180] P. Touboul,et al. Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis , 2011, Journal of cardiovascular pharmacology.
[181] C. Schmid,et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. , 2005, The Cochrane database of systematic reviews.
[182] M. Chien,et al. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta‐analysis , 2012, Diabetes, obesity & metabolism.
[183] D. Whiteman,et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. , 2007, European journal of cancer.
[184] E. Haddad,et al. Meats, Processed Meats, Obesity, Weight Gain and Occurrence of Diabetes among Adults: Findings from Adventist Health Studies , 2008, Annals of Nutrition and Metabolism.
[185] Mohammad Hassan Murad,et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.
[186] J. L. Botha,et al. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes , 1997, Epidemiology and Infection.
[187] G. Viberti. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes. , 2005, Journal of diabetes and its complications.
[188] D. Ryan,et al. Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release , 2014, Diabetes Care.
[189] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[190] Benjamin Cheong,et al. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. , 2002, Diabetes care.
[191] S. Shott,et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.
[192] James D Dziura,et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.
[193] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[194] M. Freemark,et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. , 2002, The Journal of pediatrics.
[195] J. Ge,et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. , 2010, Diabetes research and clinical practice.
[196] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[197] M. Hanefeld,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.
[198] S. McClave,et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). , 2009, JPEN. Journal of parenteral and enteral nutrition.
[199] J. Ballenger. Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis , 2012 .
[200] E. Jude,et al. Managing complications of the diabetic foot , 2009, BMJ : British Medical Journal.
[201] R. Henry,et al. Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release , 2014, Diabetes Care.
[202] B. Shields,et al. Insulin Mutation Screening in 1,044 Patients With Diabetes , 2008, Diabetes.
[203] William S. Yancy,et al. Nutrition Therapy Recommendations for the Management of Adults With Diabetes , 2013, Diabetes Care.
[204] J. Saver,et al. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis. , 2011, Atherosclerosis.
[205] Jiaquan Xu,et al. Deaths: final data for 2006. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[206] R. Goldbohm,et al. Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[207] A. Vinik,et al. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease , 2013, Journal of diabetes investigation.
[208] Edward M. Hitchcock,et al. Obesity and other risk factors: the national survey of U.S. long-haul truck driver health and injury. , 2014, American journal of industrial medicine.
[209] B. Charbonnel,et al. Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin , 2012, Current medical research and opinion.
[210] Michael Mauer,et al. Histopathology of diabetic nephropathy. , 2007, Seminars in nephrology.
[211] J. Valls-Solé,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society , 2010, European journal of neurology.
[212] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[213] J. Stamler. Clofibrate and niacin in coronary heart disease. , 1975, JAMA.
[214] Dennis D. Kim,et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. , 2005, Diabetes care.
[215] R. Toto,et al. Hypertension in patients with diabetes , 2000, Postgraduate medicine.
[216] Walter T Ambrosius,et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.
[217] P. Sönksen,et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.
[218] P. Mitchell,et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.
[219] A. Vinik,et al. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia. , 2014, Pain medicine.
[220] J. Pirart. Why Don't We Teach and Treat Diabetic Patients Better? , 1978, Diabetes Care.
[221] N. Wenger,et al. Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study). , 2010, The American journal of cardiology.
[222] F. Sacks,et al. Combination lipid therapy in type 2 diabetes. , 2010, The New England journal of medicine.
[223] Mary T Korytkowski,et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.
[224] P. Froguel,et al. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. , 2008, Endocrine reviews.
[225] Sheri R. Colberg,et al. Balance Training Reduces Falls Risk in Older Individuals With Type 2 Diabetes , 2010, Diabetes Care.
[226] C. Bogardus,et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.
[227] J. Christiansen,et al. Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes , 2008, Diabetes, obesity & metabolism.
[228] L. Jovanovič,et al. Frequent Monitoring of A1C During Pregnancy as a Treatment Tool to Guide Therapy , 2010, Diabetes Care.
[229] S. Heller,et al. Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy , 2007, Diabetes Care.
[230] A. Vinik. A medicinal food provides food for thought in managing diabetic neuropathy. , 2013, The American journal of medicine.
[231] J. Tamsma,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[232] C. Goldsmith,et al. A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events , 2007, Diabetes Care.
[233] I. Harman-boehm,et al. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[234] S. Johnson,et al. A longitudinal analysis of adherence and health status in childhood diabetes. , 1992, Journal of pediatric psychology.
[235] Vivian A Fonseca,et al. Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence , 2010, Diabetes, obesity & metabolism.
[236] D. Sandman,et al. A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. , 2001, Archives of physical medicine and rehabilitation.
[237] F. Ashcroft,et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.
[238] Anahit Mehrabyan,et al. Diagnosis and management of diabetic autonomic neuropathy , 2003, Comprehensive therapy.
[239] E. Eugster,et al. Position Statement: Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes , 2006, Pediatrics.
[240] J. Adamson,et al. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease , 2012 .
[241] J. Callés-Escandon,et al. Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients , 2013, Diabetes Care.
[242] B. Heitmann,et al. Should glycemic index and glycemic load be considered in dietary recommendations? , 2008, Nutrition reviews.
[243] K. Hemminki,et al. The impact of type 2 diabetes mellitus on cancer‐specific survival , 2012, Cancer.
[244] B. Mokhlesi,et al. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea , 2005, Sleep and Breathing.
[245] J. Leahy. A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes , 2007 .
[246] A. Stagnaro-Green,et al. Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. , 1995, The Mount Sinai journal of medicine, New York.
[247] T. Kasai,et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. , 2008, Chest.
[248] F. Greenway,et al. Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes , 2013, Diabetes Care.
[249] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[250] J. Lupski,et al. Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence‐Based Review) , 2009, PM & R : the journal of injury, function, and rehabilitation.
[251] R. Aronson,et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial , 2014, The Lancet.
[252] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.
[253] Yogish C Kudva,et al. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. , 2009, The Journal of clinical endocrinology and metabolism.
[254] A. Rissanen,et al. Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines , 2003, International Journal of Obesity.
[255] E. Braunwald,et al. Coronary heart disease Acute coronary syndromes and diabetes : is intensive lipid lowering beneficial ? Results of the PROVE IT-TIMI 22 trial , 2006 .
[256] A. R. Mangels,et al. Position of the American Dietetic Association: vegetarian diets. , 2009, Journal of the American Dietetic Association.
[257] J. McGill,et al. Diabetes and cancer--an AACE/ACE consensus statement. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[258] R. Scharfmann,et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.
[259] A. Vinik,et al. Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes , 2010, Diabetes, metabolic syndrome and obesity : targets and therapy.
[260] Ian J. Deary,et al. Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study , 2014, Diabetes Care.
[261] J. Foody,et al. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study). , 2010, The American journal of cardiology.
[262] Hyuni Lee,et al. Improvement of cardiovascular risk factors in patients with type 2 diabetes after long‐term continuous subcutaneous insulin infusion , 2008, Diabetes/metabolism research and reviews.
[263] D. Muchmore,et al. Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[264] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.
[265] Winfried März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005 .
[266] Michael Larsen,et al. Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. , 2004, Acta ophthalmologica Scandinavica.
[267] G. Moneta,et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .
[268] A. Vinik,et al. Pioglitazone treatment improves nitrosative stress in type 2 diabetes. , 2006, Diabetes care.
[269] P. Bennett,et al. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. , 1990, Diabetes/metabolism reviews.
[270] R. Freeman,et al. Diabetic autonomic neuropathy. , 2003, Diabetes care.
[272] R. Freeman,et al. Treatment‐induced diabetic neuropathy: A reversible painful autonomic neuropathy , 2010, Annals of neurology.
[273] J. Dorca,et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. , 2014, The Journal of infection.
[274] D. Leroith,et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. , 2010, Cancer research.
[275] G. Cruccu,et al. Tools for Assessing Neuropathic Pain , 2009, PLoS medicine.
[276] Andrew J.M. Boulton,et al. Neuropathic Diabetic Foot Ulcers , 2004 .
[277] G. Ning,et al. Diabetes and cancer relationships (糖尿病与肿瘤的关联性) , 2013, Journal of diabetes.
[278] S. Dagogo-Jack. Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum , 2010, Nature Reviews Endocrinology.
[279] M. Phillip,et al. Use of Insulin Pump Therapy in the Pediatric Age-Group , 2007, Diabetes Care.
[280] J. Murray. A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial , 2012 .
[281] H. Kuipers,et al. Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes. , 2006, Medicine and science in sports and exercise.
[282] A. Cherrington,et al. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.
[283] Dariush Mozaffarian,et al. Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2010, Circulation.
[284] R. Bergenstal,et al. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. , 2009, Current medical research and opinion.
[285] J. Sturis,et al. Combination of the insulin sensitizer, pioglitazone, and the long‐acting GLP‐1 human analog, liraglutide, exerts potent synergistic glucose‐lowering efficacy in severely diabetic ZDF rats , 2008, Diabetes, obesity & metabolism.
[286] R. Vigersky,et al. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society , 2013, Diabetes Care.
[287] G. Bray,et al. Medical Therapy for the Patient With Obesity , 2012, Circulation.
[288] L. Heinemann,et al. Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study , 2011, Diabetologia.
[289] F. Ashcroft,et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.
[290] A. Donker,et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial , 2010, BMJ : British Medical Journal.
[291] O. Ober. Diabetes Prevention Program , 2012 .
[292] Do Peterson,et al. Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.
[293] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[294] J. Tuomilehto,et al. Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range , 2010, Diabetes Care.
[295] R. Freeman,et al. Diabetic Neuropathy , 2010, Diabetes Care.
[296] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[297] D. Ryan,et al. Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients , 2006, Diabetes, obesity & metabolism.
[298] V. Mohan,et al. Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic Groups , 2009, Diabetes Care.
[299] G. Bray,et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.
[300] Nish Chaturvedi,et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. , 2012, The New England journal of medicine.
[301] R. Hughes,et al. Duloxetine for treating painful neuropathy or chronic pain. , 2009, The Cochrane database of systematic reviews.
[302] 入江 潤一郎,et al. Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .
[303] B. Hummer,et al. Pancreatic safety of incretin-based drugs--FDA and EMA assessment. , 2014, The New England journal of medicine.
[304] C. O'connor,et al. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes , 2010, Diabetes Care.
[305] Dennis D. Kim,et al. The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes , 2007, Annals of Internal Medicine.
[306] T. Nurmikko,et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.
[307] Markku Peltonen,et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery , 2004 .
[308] R. Plodkowski,et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society: executive summary. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[309] W. Ambrosius,et al. Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.
[310] Bengt Persson,et al. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.
[311] Nancy R Cook,et al. Statins: new American guidelines for prevention of cardiovascular disease , 2013, The Lancet.
[312] J. Talbot,et al. Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion and Conventional Insulin Therapy in Type II Diabetic Patients Poorly Controlled With Sulfonylureas , 1991, Diabetes Care.
[313] M. Hamburg,et al. Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. , 2010, The New England journal of medicine.
[314] G. Van den Berghe,et al. Glucose Variability and Mortality in Patients Hospitalized With Acute Myocardial Infarction , 2012, Circulation. Cardiovascular quality and outcomes.
[315] A. Minder,et al. Frequency of blood glucose testing in well educated patients with diabetes mellitus type 1: how often is enough? , 2013, Diabetes research and clinical practice.
[316] R. Ness-Abramof. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2010 .
[317] S. Colagiuri,et al. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[318] F. Rubino,et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[319] P. Wilson,et al. The epidemiology of impaired glucose tolerance and hypertension. , 1991, American heart journal.
[320] O G Kolterman,et al. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[321] Thomas Penzel,et al. Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea , 2003, Circulation.
[322] T. Marrie,et al. Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. , 2010, The American journal of medicine.
[323] E. Feldman,et al. Evidence-based guideline: Treatment of painful diabetic neuropathy , 2011, Neurology.
[324] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[325] G. Moneta,et al. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes , 2007 .
[326] M. Zwahlen,et al. Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[327] A. Vinik,et al. Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.
[328] A. Nicolucci,et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). , 2010, Archives of internal medicine.
[329] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[330] An Pan,et al. Increased mortality risk in women with depression and diabetes mellitus. , 2011, Archives of general psychiatry.
[331] Ray Burke,et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. , 2005, Diabetes care.
[332] A. Vinik,et al. Small fiber neuropathy is associated with the metabolic syndrome. , 2005, Metabolic syndrome and related disorders.
[333] D. Klonoff,et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.
[334] Daniel W. Jones,et al. Seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC 7): Resetting the hypertension sails , 2003 .
[335] P. Peduzzi,et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.
[336] B. Goldstein,et al. Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies , 2013, Diabetes Therapy.
[337] R. Schlienger,et al. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK – a nested case–control analysis , 2014, Diabetes, obesity & metabolism.
[338] A. Kitabchi,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.
[339] S. Redline,et al. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. , 2009, Sleep.
[340] S. Tunis,et al. Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada , 2010, Applied health economics and health policy.
[341] Craig I Coleman,et al. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. , 2010, JAMA.
[342] M. Fiatarone,et al. Effects of High-Intensity Strength Training on Multiple Risk Factors for Osteoporotic Fractures: A Randomized Controlled Trial , 1994 .
[343] B. Zinman,et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. , 2006, The New England journal of medicine.
[344] C. Whitney,et al. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2014, MMWR. Morbidity and mortality weekly report.
[345] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.
[346] Alicja Wolk,et al. Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.
[347] H. Tritschler,et al. Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[348] J. Hsia,et al. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.
[349] John D. Clark,et al. Food label use and awareness of nutritional information and recommendations among persons with chronic disease. , 2009, The American journal of clinical nutrition.
[350] T. Wilt,et al. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[351] C. Rock,et al. Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial , 2011, Obesity.
[352] D. Mikhailidis,et al. Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus , 2003, Angiology.
[353] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[354] L. Svetkey,et al. Patient characteristics associated with receipt of lifestyle behavior advice. , 2009, North Carolina medical journal.
[355] E. Giovannucci,et al. A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[356] K. Schulman,et al. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. , 2010, Diabetes technology & therapeutics.
[357] Po Box,et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies , 2006 .
[358] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[359] N. Chaturvedi,et al. Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study. , 2014, The Journal of clinical endocrinology and metabolism.
[360] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[361] R. Meeusen,et al. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients , 2009, Diabetologia.
[362] M. Bromberg,et al. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. , 2001, Diabetes care.
[363] D. Braun,et al. A cohort study of acute pancreatitis in relation to exenatide use , 2011, Diabetes, obesity & metabolism.
[364] S. Inzucchi,et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 , 2013, Diabetes Care.
[365] M. Stumvoll,et al. Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes , 2001, Annals of Internal Medicine.
[366] Dan Ziegler,et al. Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.
[367] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[368] P. Ridker,et al. An assessment by the Statin Diabetes Safety Task Force: 2014 update. , 2014, Journal of clinical lipidology.
[369] T. Trinidad,et al. The potential health benefits of legumes as a good source of dietary fibre , 2009, British Journal of Nutrition.
[370] N. Levinsky. Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.
[371] Alex J Sutton,et al. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.
[372] L. Jovanovic-Peterson. Medical Management of Pregnancy Complicated by Diabetes , 2009 .
[373] K. Gadde,et al. Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) , 2011, Obesity.
[374] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[375] S. Kumar,et al. Triple oral fixed‐dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study‐II) , 2011, Diabetes, obesity & metabolism.
[376] C. Gieger,et al. Replication of restless legs syndrome loci in three European populations , 2009, Journal of Medical Genetics.
[377] Bruce W Bode,et al. Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[378] L. Sciacca,et al. Use of insulin detemir during pregnancy. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[379] Lawrence A Leiter,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines , 2006, Current opinion in cardiology.
[380] U. Munzel,et al. Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.
[381] Eva L Feldman,et al. Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.
[382] J. Dillinger,et al. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. , 2012, American heart journal.
[383] S. Redline,et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. , 2012, Sleep.
[384] T. Wadden,et al. Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010, Annals of Internal Medicine.
[385] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[386] Rayaz A. Malik,et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.
[387] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[388] A. Vinik,et al. Recognizing and treating diabetic autonomic neuropathy. , 2001, Cleveland Clinic journal of medicine.
[389] R. Horwitz,et al. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. , 2014, The American journal of medicine.
[390] T. Gislason,et al. Role of snoring and daytime sleepiness in occupational accidents. , 2001, American journal of respiratory and critical care medicine.
[391] P. Marik,et al. Original ResearchCritical Care MedicineToward Understanding Tight Glycemic Control in the ICU: A Systematic Review and Metaanalysis , 2010 .
[392] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[393] S. Norris,et al. Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus , 2010, The Annals of Family Medicine.
[394] B. Kavanagh,et al. Clinical practice. Glycemic control in the ICU. , 2010, The New England journal of medicine.
[395] Michael E. Miller,et al. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[396] R. Hanson,et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.
[397] Kristian Thorlund,et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. , 2014, JAMA.
[398] E. Cummins,et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. , 2010, Health technology assessment.
[399] Kenneth L. Jones,et al. Medical writer , 2019, Combatting Burnout.
[400] P. Quigley,et al. Effect of a group-based exercise program on balance in elderly , 2007, Clinical interventions in aging.
[401] G. Bakris,et al. Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga , 2014, Diabetes Care.
[402] A. Tighe,et al. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications , 2008, Expert review of cardiovascular therapy.
[403] A. Keech,et al. Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome , 2008, Diabetes Care.
[404] J. Sowers,et al. Hypertension in patients with diabetes , 2000, Postgraduate medicine.
[405] Shari Bolen,et al. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus , 2007, Annals of Internal Medicine.
[406] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[407] Anthony Delaney,et al. Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Metaanalysis , 2009 .
[408] J. Weissberg-Benchell,et al. Insulin pump therapy: a meta-analysis. , 2003, Diabetes care.
[409] Robert A Greevy,et al. Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus , 2012, Annals of Internal Medicine.
[410] O. Axelson,et al. Mortality among taxi drivers in Rome: a cohort study. , 1994, American journal of industrial medicine.
[411] A. Berghold,et al. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[412] Daniel B. Jones,et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[413] A. Vinik,et al. Exercise improves gait, reaction time and postural stability in older adults with type 2 diabetes and neuropathy. , 2014, Journal of diabetes and its complications.
[414] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[415] S. Roze,et al. Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK , 2005 .
[416] A. Minihane,et al. Impact of Oil used by the Frying Industry on Population Fat Intake , 2007, Critical reviews in food science and nutrition.
[417] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[418] F. Chan,et al. Cardiovascular Diabetology BioMed Central Original investigation , 1995 .
[419] M. Rowley,et al. GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes , 1994, Diabetes.
[420] G. Virgili,et al. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. , 2009, The Cochrane database of systematic reviews.
[421] S. Toubro,et al. Effect of Orlistat on Weight Regain and Cardiovascular Risk Factors Following a Very-Low-Energy Diet in Abdominally Obese Patients , 2007, Diabetes Care.
[422] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[423] Diane M. Miller,et al. Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial , 2010, Circulation.
[424] Craig Wilson,et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. , 2013, The New England journal of medicine.
[425] D. Riche,et al. Thiazolidinediones and Risk of Repeat Target Vessel Revascularization Following Percutaneous Coronary Intervention , 2007, Diabetes Care.
[426] M. Minshall,et al. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[427] J. Mechanick,et al. American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[428] D. Makris,et al. Diabetes and Hemoglobin A1c as Risk Factors for Nosocomial Infections in Critically Ill Patients , 2013, Critical care research and practice.
[429] Roberto Ferrari,et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. , 2004, European heart journal.
[430] S. Inzucchi,et al. Clinical practice. Management of hyperglycemia in the hospital setting. , 2006, The New England journal of medicine.
[431] Guillermo,et al. Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized, controlled study , 2022 .
[432] A. Lewiński,et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[433] Z. Bloomgarden,et al. What role will 'gliptins' play in glycemic control? , 2008, Cleveland Clinic journal of medicine.
[434] S. Freedland,et al. Obesity and prostate cancer: weighing the evidence. , 2013, European urology.
[435] L. Zelek,et al. Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.
[436] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[437] P. Bennett,et al. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. , 1983, The New England journal of medicine.
[438] G. Moneta. Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial , 2009 .
[439] P. Knight. Principles and Practice of Geriatric Medicine , 1987 .
[440] Lizheng Shi,et al. Economic burden of hypoglycemia in patients with Type 2 diabetes , 2012, Expert review of pharmacoeconomics & outcomes research.
[441] J. Arezzo,et al. Diabetic somatic neuropathies. , 2004, Diabetes care.
[442] J. Stradling,et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes , 2007, Thorax.
[443] A. Vinik,et al. Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function. , 2013, Diabetes technology & therapeutics.
[444] D. Wade,et al. The natural history of acute painful neuropathy in diabetes mellitus. , 1983, Journal of neurology, neurosurgery, and psychiatry.
[445] N. Shah,et al. Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia , 2012, Diabetes Care.
[446] Stephen O’Riordana,et al. Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .
[447] A. Goto,et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis , 2013, BMJ.
[448] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[449] Claude Bouchard,et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.
[450] L. Sjöström,et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.
[451] D. Maahs,et al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium , 2014 .
[452] J. Fain. Diabetes Prevention Program: Education is Vital , 2002, The Diabetes educator.
[453] R. Freeman,et al. Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy , 2011, Diabetes Care.
[454] T. Larson,et al. Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes , 2007, Diabetes Care.
[455] L. Groop,et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes--associated HLA genotypes in women with gestational diabetes mellitus. , 2002, Diabetes care.
[456] M. Mendu,et al. Diabetes mellitus and community-acquired bloodstream infections in the critically ill. , 2014, Journal of critical care.
[457] K. Nørgaard,et al. [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes]. , 2010, Ugeskrift for laeger.
[458] B. Yeap,et al. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study , 2008, Diabetologia.
[459] H. Krumholz,et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.
[460] D. Hillman,et al. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. , 2012, The Journal of clinical endocrinology and metabolism.
[461] A. Vinik,et al. Relation between risk of falling and postural sway complexity in diabetes. , 2012, Gait & posture.
[462] R. Haring,et al. Surgical therapy of hyperinsulinism , 1981, World Journal of Surgery.
[463] D. Rybin,et al. Weight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With Diabetes , 2011, Diabetes Care.
[464] P. Cryer. Death during intensive glycemic therapy of diabetes: mechanisms and implications. , 2011, The American journal of medicine.
[465] J. Lecerf,et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. , 2010, The American journal of clinical nutrition.
[466] R. Pettis,et al. Microneedle delivery: clinical studies and emerging medical applications. , 2012, Therapeutic delivery.
[467] M. Hanefeld,et al. The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo‐controlled trial , 2002, Diabetes, obesity & metabolism.
[468] G. Umpierrez,et al. Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes , 2012, Journal of diabetes science and technology.
[469] P. Toth. Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis , 2012 .
[470] J. N. Fisher,et al. Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.
[471] O. Ganda. Dyslipidemia: Pathogenesis and Management , 2010 .
[472] David D. Dore,et al. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide , 2009, Current medical research and opinion.
[473] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[474] M. Pendergrass,et al. Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin , 2010, Diabetes Care.
[475] D. Suh,et al. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004 , 2009, Journal of hypertension.
[476] A. Jenkins,et al. Feasibility of Adjacent Insulin Infusion and Continuous Glucose Monitoring via the Medtronic Combo-Set , 2013, Journal of diabetes science and technology.
[477] A. Vinik,et al. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. , 2013, Diabetes technology & therapeutics.
[478] J. Olson,et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme , 2013, Diabetologia.
[479] G. Umpierrez,et al. PHARMACOLOGIC TREATMENT OF TYPE 2 DIABETES ( AVELLA , SECTION EDITOR ) Sulfonylureas : A New Look at Old Therapy , 2014 .
[480] F. Sacks,et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.
[481] C. Whitney,et al. Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2013, MMWR. Morbidity and mortality weekly report.
[482] J. Ochoa,et al. NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.
[483] J. Rosenstock,et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. , 2013, The American journal of medicine.
[484] T. Gardner,et al. Predicting Development of Proliferative Diabetic Retinopathy , 2013, Diabetes Care.
[485] R. Little,et al. Measurement of Hba(1C) in patients with chronic renal failure. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[486] C. Rosebraugh,et al. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy. , 2010, The New England journal of medicine.
[487] Dennis D. Kim,et al. A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) , 2013, Obesity.
[488] L. Jovanovic,et al. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes , 2011, Diabetes/metabolism research and reviews.
[489] H. Fields,et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials , 2001, Journal of the Neurological Sciences.
[490] H. Krumholz,et al. Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes , 2005, Circulation.
[491] John B Buse,et al. Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.
[492] J. Forrester,et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.
[493] A. Boulton,et al. Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy , 2013, Diabetes Care.
[494] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[495] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[496] S. Kusunoki,et al. Autoimmune mechanisms in peripheral neuropathies , 1990, Annals of neurology.
[497] S. Mudaliar,et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. , 2003, Diabetes care.
[498] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[499] A. Vinik. The approach to the management of the patient with neuropathic pain. , 2010, The Journal of clinical endocrinology and metabolism.
[500] J. K. Radder,et al. Course of HbA1c in non-diabetic pregnancy related to birth weight. , 2013, The Netherlands journal of medicine.
[501] C Osmond,et al. Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.
[502] A. Thanopoulou,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[503] J. Assal,et al. [Long-term complications in diabetes mellitus]. , 1989, Acta medica portuguesa.
[504] Salim Yusuf,et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. , 2012, The New England journal of medicine.
[505] Christopher T Sempos,et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. , 2006, The American journal of cardiology.
[506] W. Rathmann,et al. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis. , 2014, Primary care diabetes.
[507] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[508] Brenda R. Hemmelgarn,et al. Notice , 2012, Kidney International Supplements.
[509] S. Bowlin,et al. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. , 2009, Clinical therapeutics.
[510] M. Tonelli,et al. Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease , 2012, Annals of Internal Medicine.
[511] A. Vaag,et al. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial , 2009, Diabetologia.
[512] E. Horton,et al. Exercise in the Management of Type 1 Diabetes Mellitus , 2003, Reviews in Endocrine and Metabolic Disorders.
[513] R Peto,et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.
[514] A. Astrup,et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide , 2011, International Journal of Obesity.
[515] C. Bouchard,et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. , 2014, JAMA.
[516] C. Kapitza,et al. Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin , 2010, Diabetes Care.
[517] J. Krinsley,et al. Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.
[518] A. Kriska,et al. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the Look AHEAD Study , 2013, Obesity.
[519] Nish Chaturvedi,et al. Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.
[520] Irl B Hirsch,et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[521] R. Klein,et al. Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.
[522] Michael E. Miller,et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.
[523] V. Vuksan,et al. Fiber facts: Benefits and recommendations for individuals with type 2 diabetes , 2009, Current diabetes reports.
[524] D. Bliwise,et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. , 2000, Obesity research.
[525] D. Yue,et al. The relationship among pain, sensory loss, and small nerve fibers in diabetes. , 2006, Diabetes care.
[526] B. Hemmelgarn,et al. Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. , 2006, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[527] L. Niskanen,et al. Depression and major weight gain: a 6-year prospective follow-up of outpatients. , 2013, Comprehensive psychiatry.
[528] E. Stålberg,et al. Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies , 2008, Journal of Neurology.
[529] J. Rosenstock,et al. Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets , 2012, Diabetes Care.
[530] Bernard Friedman,et al. Multiple hospitalizations for patients with diabetes. , 2003, Diabetes care.
[531] A. Vaag,et al. Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People , 2008, Circulation.
[532] D. Bruttomesso,et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience , 2008, Acta Diabetologica.
[533] A. Vinik,et al. Diabetic neuropathy in older adults. , 2008, Clinics in geriatric medicine.
[534] K. Mandroukas,et al. Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy , 2007, British Journal of Sports Medicine.
[535] E. Lewis,et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. , 2008, The New England journal of medicine.
[536] M. Riddle,et al. Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes , 2009, Diabetes Care.
[537] Deepak L. Bhatt,et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.
[538] Loyd,et al. SIMVASTATIN AND NIACIN , ANTIOXIDANT VITAMINS , OR THE COMBINATION FOR THE PREVENTION OF CORONARY DISEASE , 2001 .
[539] A. Lincoff,et al. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. , 2007, JAMA.
[540] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[541] F. Ovalle. Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis , 2010 .
[542] T. Davis,et al. Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting , 2009, Diabetes Care.
[543] A. Berghold,et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis , 2008, Diabetologia.
[544] V. Messina,et al. Position of the American Dietetic Association: Vegetarian Diets , 2022 .
[545] I. Constable,et al. Prevalence of Diabetic Complications in Relation to Risk Factors , 1986, Diabetes.
[546] R. Henry,et al. New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). , 2013, Journal of diabetes and its complications.
[547] A. Vinik,et al. A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.
[548] A. Powell. Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study , 2012 .
[549] E. Sivan,et al. Macrosomia in well controlled CSII treated Type I diabetic pregnancy , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[550] P. Valensi,et al. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. , 2005, Journal of diabetes and its complications.
[551] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.
[552] R. Asmar,et al. Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials. , 2009, Diabetes & metabolism.
[553] G. R. Jackson,et al. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial. , 2014, JAMA ophthalmology.
[554] A. Peltier,et al. Painful diabetic neuropathy. , 2014, BMJ.
[555] S. Studenski,et al. Relationship Between Vitamin B12 and Sensory and Motor Peripheral Nerve Function in Older Adults , 2012, Journal of the American Geriatrics Society.
[556] E. Masson,et al. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog) , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[557] Tetsuro Tsujimoto,et al. Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis , 2012, PloS one.
[558] M. Massi-Benedetti,et al. Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine , 2010, Diabetes, obesity & metabolism.
[559] R. Pawlak,et al. Benefits, barriers, self-efficacy and knowledge regarding healthy foods; perception of African Americans living in eastern North Carolina , 2009, Nutrition research and practice.
[560] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[561] P. Whelton,et al. Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2005 .
[562] D. Matthews,et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.
[563] Therese Miller,et al. Aspirin for the Primary Prevention of Cardiovascular Events , 2009 .
[564] N. Marchionni,et al. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. , 2008, Diabetes research and clinical practice.
[565] R. Loomba,et al. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status , 2009, Advances in therapy.
[566] N. Weissman,et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. , 2010, The New England journal of medicine.
[567] P. Rosenblit. Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy? , 2012, Current Cardiology Reports.
[568] Jennette P. Moreno,et al. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2014, Current Atherosclerosis Reports.
[569] P. Verdecchia,et al. Prognostic value of ambulatory blood pressure : current evidence and clinical implications. , 2000, Hypertension.
[570] Grant D. Huang,et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. , 2011, Journal of diabetes and its complications.
[571] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[572] Desmond E. Williams,et al. Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.
[573] Mark Woodward,et al. Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.
[574] M. Bromberg,et al. Painful sensory polyneuropathy associated with impaired glucose tolerance , 2001, Muscle & nerve.
[575] R. Devine,et al. Hypoglycemia: minimizing its impact in type 2 diabetes. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[576] L. Martens,et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. , 1998, Clinical therapeutics.
[577] F. Gueyffier,et al. Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials , 2012, PLoS medicine.
[578] J. Dostrovsky,et al. Neuropathic pain , 2008, Neurology.
[579] B. Zinman,et al. The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Stu , 2013, Circulation.
[580] E. Feskens,et al. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.
[581] D. Pereg,et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.
[582] Robert J. Anderson,et al. Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis , 2009, Diabetes.
[584] Steven A. Smith,et al. Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.
[585] D. Owens,et al. Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study , 2013, BMJ Open.
[586] Dennis D. Kim,et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. , 2005, Diabetes care.
[587] F. Crea,et al. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. , 2009, European heart journal.
[588] L. Rydén,et al. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[589] J. Lupski,et al. Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) , 2009, Neurology.
[590] K. Jablonski,et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. , 2003, Diabetes care.
[591] John Chalmers,et al. Clinical Practice Guidelines for the Management of Hypertension in the Community , 2014, Journal of clinical hypertension.
[592] D. Robbins,et al. Diabetes : clinical science in practice , 1995 .
[593] G. Umpierrez,et al. Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes , 2014, Diabetes Care.
[594] I. Hirsch,et al. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.
[595] James W. Anderson,et al. Grain Foods and Health: A Primer for Clinicians , 2008, The Physician and sportsmedicine.
[596] A. Boulton,et al. Role of Experimental Socks in the Care of the High-Risk Diabetic Foot: A multicenter patient evaluation study , 1993, Diabetes Care.
[597] Bruce W Bode,et al. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. , 2005, Diabetes care.
[598] L. Aronne,et al. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. , 2002, Diabetes care.
[599] J. Fleg,et al. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.
[600] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[601] B. J. Gersh. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2011 .
[602] A. Peters,et al. Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems , 2011, Diabetes Care.
[603] M. Noakes,et al. Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes. , 2008, The American journal of clinical nutrition.
[604] R. Plodkowski,et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists/the American College of Endocrinology and the Obesity Society. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[605] M. Laakso,et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.
[606] J. Danesh,et al. Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.
[607] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[608] T. Harrison. Faculty Opinions recommendation of Lifestyle intervention for pre-diabetic neuropathy. , 2006 .
[609] H. El‐Serag,et al. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[610] T. Jacobson. Overcoming ‘Ageism’ Bias in the Treatment of Hypercholesterolaemia , 2006, Drug safety.
[611] J. McGill,et al. Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants , 2013, Diabetes Care.
[612] Limin Peng,et al. Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes , 2013, Diabetes Care.
[613] D. Bruttomesso,et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[614] Jeffrey A. Cohen,et al. Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy , 2011, PM & R : the journal of injury, function, and rehabilitation.
[615] G. Pugliese,et al. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis , 2007, Diabetes Care.
[616] M. Spüler,et al. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. , 1992, Journal of diabetes and its complications.
[617] L. Grohskopf,et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season , 2014, MMWR. Morbidity and mortality weekly report.
[618] J. Rosenbauer,et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.
[619] Claude Lenfant,et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. , 2003, Hypertension.
[620] H. Gharib,et al. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[621] E. Rimm,et al. Body mass index and risk of prostate cancer in U.S. health professionals. , 2003, Journal of the National Cancer Institute.
[622] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[623] Nathan Efron,et al. Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.
[624] Z. Al-Aly,et al. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[625] W. Tamborlane,et al. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device , 2012, Pediatric diabetes.
[626] S. Boutreux,et al. Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[627] Johan Groeneveld,et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.
[628] Nilay Kumar,et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. , 2007, Diabetes technology & therapeutics.
[629] Rury R Holman,et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). , 2003, Kidney international.
[630] D. Nathan,et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. , 2012, The New England journal of medicine.
[631] M. S. Lewis,et al. Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes , 2011, Annals of Internal Medicine.
[632] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[633] J. Eng,et al. Resistance and Agility Training Reduce Fall Risk in Women Aged 75 to 85 with Low Bone Mass: A 6‐Month Randomized, Controlled Trial * , 2004, Journal of the American Geriatrics Society.
[634] Markolf Hanefeld,et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.
[635] G. Landman,et al. Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes , 2009, Diabetes Care.
[636] S. Aronoff,et al. Exenatide is Non-inferior to Insulin in Reducing HbA1c: An Integrated Analysis of 1423 Patients with Type 2 Diabetes , 2010, Postgraduate medicine.
[637] G. Paolisso,et al. Adiposity Predicts Cognitive Decline in Older Persons with Diabetes: A 2-Year Follow-Up , 2010, PloS one.
[638] 康生 大久保,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .
[639] A. Vinik,et al. Adding Insulin Glargine Versus Rosiglitazone , 2007, Diabetes Care.
[640] D. Bruttomesso,et al. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy , 2009, Diabetes/metabolism research and reviews.
[641] C. Janson,et al. CPAP treatment of a population-based sample--what are the benefits and the treatment compliance? , 2006, Sleep medicine.
[642] E. Ford,et al. Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.
[643] H. Nawaz,et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. , 2003, Diabetes care.
[644] B. Klein,et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.